Patented Medicine Prices and R&D Spending in Canada, 2023 Annual Report

The Patented Medicine Prices Review Board Canada's 2023 Annual Report reviews trends in the prices and sales of patented medicines in Canada. The report also sets out findings on spending on pharmaceutical research and development in Canada, as well as updated information on the PMPRB’s price review and reporting activities. The dataset was last updated on the open_canada platform in April 2026.

Use Cases

• Analyze trends in patented medicine prices based on the price review activities mentioned in the description
• Model pharmaceutical sales volumes in Canada based on the sales data referenced
• Assess research and development investment levels in the Canadian pharmaceutical sector based on the spending findings

Strengths

• Report is published by the authoritative Patented Medicine Prices Review Board Canada.
• Data covers multiple facets of the pharmaceutical market, including pricing, sales, and R&D spending.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is presented in HTML format, which may complicate structured analysis.

Provenance

Source

Patented Medicine Prices Review Board Canada | Conseil d'examen du prix des médicaments brevetés Canada

Collection Method

Likely compiled from regulatory reporting and industry submissions.

Time Range

2023

Freshness

Last updated 2026-04-16 19:26:56.894117; freshness should be verified.

Geography

Canada